$CABA
Cabaletta Bio, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020024508 Filed on May 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.280M $1.230M
YoY Change 166.67%
% of Gross Profit
Research & Development $4.620M $2.761M
YoY Change 67.33%
% of Gross Profit
Depreciation & Amortization $76.00K $0.00
YoY Change
% of Gross Profit
Operating Expenses $7.895M $3.990M
YoY Change 97.87%
Operating Profit -$7.895M -$3.990M
YoY Change 97.87%
Interest Expense $410.0K $460.0K
YoY Change -10.87%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$7.490M -$3.530M
YoY Change 112.18%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.485M -$3.532M
YoY Change 111.92%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$330.2K -$156.5K
COMMON SHARES
Basic Shares Outstanding 24.03M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $131.0M
YoY Change
Cash & Equivalents $131.0M $80.24M
Short-Term Investments
Other Short-Term Assets $3.100M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $134.1M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $739.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $104.0K
YoY Change
Total Long-Term Assets $843.0K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $134.1M
Total Long-Term Assets $843.0K
Total Assets $135.0M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.991M
YoY Change
Accrued Expenses $600.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.256M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.256M
Total Long-Term Liabilities $0.00
Total Liabilities $3.300M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$40.44M
YoY Change
Common Stock $172.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $131.7M -$19.05M
YoY Change
Total Liabilities & Shareholders Equity $135.0M
YoY Change

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$7.485M -$3.532M
YoY Change 111.92%
Depreciation, Depletion And Amortization $76.00K $0.00
YoY Change
Cash From Operating Activities -$4.931M -$2.265M
YoY Change 117.7%
INVESTING ACTIVITIES
Capital Expenditures $226.0K $180.0K
YoY Change 25.56%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$226.0K -$180.0K
YoY Change 25.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$44.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -44.00K 49.66M
YoY Change -100.09%
NET CHANGE
Cash From Operating Activities -4.931M -2.265M
Cash From Investing Activities -226.0K -180.0K
Cash From Financing Activities -44.00K 49.66M
Net Change In Cash -5.201M 47.22M
YoY Change -111.01%
FREE CASH FLOW
Cash From Operating Activities -$4.931M -$2.265M
Capital Expenditures $226.0K $180.0K
Free Cash Flow -$5.157M -$2.445M
YoY Change 110.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
873000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
496000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24034022
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24034022
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24034022
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24034022
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4620000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2761000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3275000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1229000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
7895000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
3990000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7895000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3990000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
410000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
458000
CY2019Q1 us-gaap Dividends
Dividends
5326000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7485000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.05
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-10690000
CY2019Q1 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
-5326000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
496000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-19052000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
873000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-7485000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-3532000
CY2020Q1 us-gaap Depreciation
Depreciation
76000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1230000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-749000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
28000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1176000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-302000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
739000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40444000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
134122000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
920000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
134965000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3119000
CY2020Q1 us-gaap Assets
Assets
134965000
CY2019Q4 us-gaap Assets
Assets
141468000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1991000
CY2020Q1 caba Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1265000
CY2019Q4 caba Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
2227000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3256000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3147000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
172153000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
171280000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32959000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
131709000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
138321000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
141468000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7485000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3532000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8858000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80235000
CY2019Q1 caba Exchange Of Convertible Preferred Stock Including Deemed Dividend
ExchangeOfConvertiblePreferredStockIncludingDeemedDividend
10090000
CY2020Q1 caba Equity Issuance Costs Incurred But Not Paid
EquityIssuanceCostsIncurredButNotPaid
147000
CY2019Q1 caba Equity Issuance Costs Incurred But Not Paid
EquityIssuanceCostsIncurredButNotPaid
1077000
CY2019Q1 caba Deferred Offering Costs In Accrued Expenses And Accounts Payable
DeferredOfferingCostsInAccruedExpensesAndAccountsPayable
547000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
216000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-44000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-797000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
352000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4931000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2265000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
226000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
180000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-226000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-180000
CY2019Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
50000000
CY2019Q1 caba Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
121000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49663000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5201000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
47218000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
136204000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33017000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
131003000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying financial statements include, but are not limited to, the fair value of common stock, stock-based compensation and the valuation allowance on the Company&#8217;s deferred tax assets. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. </p>
CY2019Q4 caba Accrued General And Administrative Services Current
AccruedGeneralAndAdministrativeServicesCurrent
297000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
563000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1522000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
101000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
177000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
198000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
268000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
158000
CY2020Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-1.5 reverse split
CY2019Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.67
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
95000
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
36000
CY2020Q1 caba Accrued Research And Development Services Current
AccruedResearchAndDevelopmentServicesCurrent
469000
CY2019Q4 caba Accrued Research And Development Services Current
AccruedResearchAndDevelopmentServicesCurrent
231000
CY2020Q1 caba Accrued General And Administrative Services Current
AccruedGeneralAndAdministrativeServicesCurrent
132000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
624000
CY2020Q1 caba Manufacturing Agreements Maximum Amount Committed
ManufacturingAgreementsMaximumAmountCommitted
2000000
CY2019Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
20762168
CY2019Q1 caba Temporary Equity Value Exchange Including Deemed Dividend
TemporaryEquityValueExchangeIncludingDeemedDividend
5326000
CY2019Q4 caba Convertible Preferred Stock Convert Into Voting Common Stock
ConvertiblePreferredStockConvertIntoVotingCommonStock
12904534
CY2019Q4 caba Convertible Preferred Stock Convert Into Non Voting Common Stock
ConvertiblePreferredStockConvertIntoNonVotingCommonStock
6409519
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21147115
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
29000000
CY2018Q2 caba Share Based Compensation Arrangement By Share Based Payment Award Common Stock Shares Modified
ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonStockSharesModified
2904000
CY2018Q2 caba Share Based Compensation Arrangement By Share Based Payment Award Common Stock Shares Modified Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonStockSharesModifiedFairValue
0.74
CY2018Q2 caba Share Based Compensation Arrangement By Share Based Payment Award Modified Common Stock Shares Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardModifiedCommonStockSharesCompensationCost
2126000
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0093
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0223
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0148
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0259
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.70
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.70
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.73
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.73
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11076000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3815889
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23043771

Files In Submission

Name View Source Status
0001564590-20-024508-index-headers.html Edgar Link pending
0001564590-20-024508-index.html Edgar Link pending
0001564590-20-024508.txt Edgar Link pending
0001564590-20-024508-xbrl.zip Edgar Link pending
caba-10q_20200331.htm Edgar Link pending
caba-20200331.xml Edgar Link completed
caba-20200331.xsd Edgar Link pending
caba-20200331_cal.xml Edgar Link unprocessable
caba-20200331_def.xml Edgar Link unprocessable
caba-20200331_lab.xml Edgar Link unprocessable
caba-20200331_pre.xml Edgar Link unprocessable
caba-ex311_8.htm Edgar Link pending
caba-ex312_7.htm Edgar Link pending
caba-ex321_10.htm Edgar Link pending
caba-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending